Product NDC: | 66302-101 |
Proprietary Name: | Remodulin |
Non Proprietary Name: | treprostinil |
Active Ingredient(s): | 20 mg/20mL & nbsp; treprostinil |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 66302-101 |
Labeler Name: | United Therapeutics Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021272 |
Marketing Category: | NDA |
Start Marketing Date: | 20020522 |
Package NDC: | 66302-101-01 |
Package Description: | 1 VIAL in 1 BOX (66302-101-01) > 20 mL in 1 VIAL |
NDC Code | 66302-101-01 |
Proprietary Name | Remodulin |
Package Description | 1 VIAL in 1 BOX (66302-101-01) > 20 mL in 1 VIAL |
Product NDC | 66302-101 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | treprostinil |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20020522 |
Marketing Category Name | NDA |
Labeler Name | United Therapeutics Corporation |
Substance Name | TREPROSTINIL |
Strength Number | 20 |
Strength Unit | mg/20mL |
Pharmaceutical Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [Chemical/Ingredient],Vasodilation [PE] |